SCHEMBL29129135

SCHEMBL29129135

CC(=O)c1ccc2cc(OCc3ccccc3S(C)(=O)=O)ccn12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BAZ2B Q9UIF8 12/20 0.51
▸ BAZ2A Q9UIF9 10/20 0.51
▸ BRD9 Q9H8M2 6/20 0.51
▸ TRIM24 O15164 1/20 0.51
▸ TAF1L Q8IZX4 1/20 0.51
▸ TRIM33 Q9UPN9 1/20 0.51
▸ F10 P00742 1/20 0.41
▸ MPO P05164 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ MAOB P27338 3/20 0.36
▸ PLK1 P53350 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ OPRD1 P41143 1/20 0.35
▸ MAOA P21397 1/20 0.35
▸ BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9281476 0.73 MAOB (0.65) MAOBMAOA
SCHEMBL29352262 0.67 BAZ2B (1.00) BAZ2BBAZ2ABRD9TRIM24TAF1L
SCHEMBL22339997 0.67 BAZ2B (1.00) BAZ2BBAZ2ABRD9TRIM24TAF1L
SCHEMBL24510745 0.64 BAZ2B (1.00) BAZ2BBAZ2ABRD9TRIM24TAF1L
SCHEMBL30569431 0.63 SLC26A4 (0.76) MEN1KMT2A
SCHEMBL23318444 0.63 BAZ2B (0.79) BAZ2BBAZ2ABRD9TRIM24TAF1L
SCHEMBL6800491 0.63 BAZ2B (0.47) BAZ2BBAZ2ABRD9CYP1A2CYP2D6
SCHEMBL15150643 0.63 MEN1 (0.49) MPOMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL23887566 0.63 KMT2A (0.57) MPOMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL19586201 0.62 BAZ2B (0.77) BAZ2BBAZ2ABRD9TRIM24TAF1L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117279636-A Methods and compounds for modulating myotonic muscular dystrophy type 1 设计治疗公司 2023-12-22 — — CN disclosed
Send feedback